FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

773522000: Mogamulizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3723810016 Mogamulizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3723811017 Mogamulizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5535201000241112 mogamulizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mogamulizumab (substance) Is a Chemokine receptor antagonist true Inferred relationship Some
Mogamulizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) false Inferred relationship Some
Mogamulizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Mogamulizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Chemokine receptor antagonist (disposition) true Inferred relationship Some
Mogamulizumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing mogamulizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Mogamulizumab (substance) Inferred relationship Some 1
Mogamulizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Mogamulizumab (substance) Inferred relationship Some 1
Mogamulizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Mogamulizumab (substance) Inferred relationship Some 1
Product containing only mogamulizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Mogamulizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start